Luca Massacesi
Florence, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 86 publications
A multispecialty consensus-based red flag checklist for the early recognition of ANCA-associated vasculitis.
Journal: Frontiers in immunology
Published: February 26, 2026
Validation of the MOG-AR Score: A Retrospective Multicenter Study.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: January 28, 2026
Therapeutic IgG- and IgM-specific proteases disarm the acetylcholine receptor autoantibodies that drive myasthenia gravis pathology.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: October 21, 2025
Real-Life Evaluation of the MOGAD Diagnostic Criteria: Application Challenges and Discrepancies.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: August 19, 2025
Effectiveness of Rituximab in rElapsiNg Multiple SclErosis previously treated with hiGhly-Active Disease modifying thErapies (RENEGADE study).
Journal: Journal of neurology
Published: July 16, 2025
Lecanemab and Alzheimer-Perusini's disease: between therapeutic hopes and regulatory challenges
Journal: Recenti progressi in medicina
Published: July 10, 2025
A proposal for a machine-learning algorithm for the prediction of seizure recurrence risk at 2 years after discontinuation of anti-seizure medications.
Journal: Seizure
Published: June 24, 2025
CD20+ T Cells in Multiple Sclerosis: From Pathogenesis to Treatment-Induced Depletion.
Journal: International journal of molecular sciences
Published: June 18, 2025
Autologous haematopoietic stem cell transplantation affects long-term progression independent of relapse activity in aggressive multiple sclerosis: a comparative matched study.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: May 26, 2025
Neuropathic pain in CASPR2 antibody disease spectrum: A systematic review.
Journal: Journal of neuroimmunology
Published: April 29, 2025
Concerns about the approval of lecanemab for Alzheimer's disease.
Journal: BMJ (Clinical research ed.)
Published: April 22, 2025
Brain [18F]FDG-PET as a marker of disease activity in a case of CASPR2 limbic encephalitis.
Journal: European journal of nuclear medicine and molecular imaging
Published: March 01, 2025
Last Updated: 09/26/2026